Evaluation of the intravenous anesthesia using propofol plus dexmedetomidine in endoscopic submucosal dissection

Evaluation of the intravenous anesthesia using propofol plus dexmedetomidine in endoscopic submucosal dissection - Evaluation of the intravenous anesthesia using propofol plus dexmedetomidine in endoscopic submucosal dissection

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013739

Enrollment

100

Registered

2014-05-09

Start date

2014-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superficial esophageal cancer or early gastric cancer

Interventions

Propofol plus dexmedetomidine Propofol alone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The superficial esophageal cancer and early gastric cancer which plan to be resected by endoscopic submucosal dissection.

Exclusion criteria

Exclusion criteria: Patients with serious cardiovascular or pulmonary disease, renal dysfunction and liver dysfunction.

Design outcomes

Primary

Measure	Time frame
Patient's hemodynamics during ESD	—

Secondary

Measure	Time frame
ESD performances	—

Countries

Japan

Contacts

Public ContactNonaka Takashi

Yokohama City University Hospital Department of Gastroenterology and Hepatology

nonaka@yokohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026